S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,020.26 (-0.04%)
DOW   37,842.79 (+0.24%)
QQQ   423.90 (-0.46%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ann Inc stock logo
ANN
ANN
$0.00
$31.69
$48.95
N/AN/A905,561 shsN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
C$0.00
C$0.06
C$0.96
N/AN/A13,293 shsN/A
ResMed Inc. stock logo
RMD
ResMed
$177.43
+2.1%
$186.42
$132.24
$243.52
$26.10B0.67998,491 shs1.10 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ResMed Inc. stock logo
RMD
ResMed
-5.95%-10.30%-9.00%+0.64%-22.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ann Inc stock logo
ANN
ANN
N/AN/AN/AN/AN/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
4.8228 of 5 stars
3.41.04.24.52.61.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ann Inc stock logo
ANN
ANN
N/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
2.70
Moderate Buy$199.2012.27% Upside

Current Analyst Ratings

Latest RMD, ANN, and GXI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
ResMed Inc. stock logo
RMD
ResMed
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$215.00 ➝ $224.00
3/27/2024
ResMed Inc. stock logo
RMD
ResMed
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$215.00
2/6/2024
ResMed Inc. stock logo
RMD
ResMed
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$227.00
1/30/2024
ResMed Inc. stock logo
RMD
ResMed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$185.00 ➝ $205.00
1/26/2024
ResMed Inc. stock logo
RMD
ResMed
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$180.00 ➝ $195.00
1/25/2024
ResMed Inc. stock logo
RMD
ResMed
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$175.00 ➝ $180.00
1/25/2024
ResMed Inc. stock logo
RMD
ResMed
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$181.00 ➝ $182.00
1/25/2024
ResMed Inc. stock logo
RMD
ResMed
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$180.00 ➝ $215.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ann Inc stock logo
ANN
ANN
N/AN/AN/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$4.22B6.18$7.50 per share23.67$28.11 per share6.31

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ann Inc stock logo
ANN
ANN
N/AN/A0.00N/AN/AN/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/A0.00N/AN/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$897.56M$6.0529.3321.532.2919.77%23.86%14.78%4/25/2024 (Confirmed)

Latest RMD, ANN, and GXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2024N/A
ResMed Inc. stock logo
RMD
ResMed
$1.93N/A-$1.93N/AN/AN/A  
1/24/2024Q2 24
ResMed Inc. stock logo
RMD
ResMed
$1.81$1.88+$0.07$2.34$1.15 billion$1.16 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ann Inc stock logo
ANN
ANN
N/AN/AN/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$1.921.08%+5.66%31.74%12 Years

Latest RMD, ANN, and GXI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/24/2024
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.481.12%2/7/20242/8/20243/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ann Inc stock logo
ANN
ANN
N/AN/AN/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
0.27
3.11
1.89

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ann Inc stock logo
ANN
ANN
N/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/A
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Ann Inc stock logo
ANN
ANN
N/A
GuestLogix Inc. stock logo
GXI
GuestLogix
N/A
ResMed Inc. stock logo
RMD
ResMed
1.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ann Inc stock logo
ANN
ANN
N/AN/AN/ANot Optionable
GuestLogix Inc. stock logo
GXI
GuestLogix
147,000N/AN/ANot Optionable
ResMed Inc. stock logo
RMD
ResMed
10,140147.09 million145.31 millionOptionable

RMD, ANN, and GXI Headlines

SourceHeadline
Analysts remain high on ResMed despite potential sleep apnea benefits from GLP-1sAnalysts remain high on ResMed despite potential sleep apnea benefits from GLP-1s
massdevice.com - April 18 at 1:12 PM
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
zacks.com - April 18 at 11:08 AM
ResMed Inc. (NYSE:RMD) Stake Raised by Mackenzie Financial CorpResMed Inc. (NYSE:RMD) Stake Raised by Mackenzie Financial Corp
marketbeat.com - April 18 at 6:31 AM
ResMed (RMD) Set to Announce Earnings on ThursdayResMed (RMD) Set to Announce Earnings on Thursday
americanbankingnews.com - April 18 at 1:58 AM
ResMed caught between two narratives: Bearish sleep apnea data and bullish analystsResMed caught between two narratives: Bearish sleep apnea data and bullish analysts
marketindex.com.au - April 18 at 1:33 AM
Tandem Investment Advisors Inc. Has $64.58 Million Stake in ResMed Inc. (NYSE:RMD)Tandem Investment Advisors Inc. Has $64.58 Million Stake in ResMed Inc. (NYSE:RMD)
marketbeat.com - April 17 at 7:32 PM
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth SankWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
fool.com - April 17 at 6:51 PM
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth SankWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
fool.com - April 17 at 6:51 PM
ResMed (NYSE:RMD) Sees Strong Trading VolumeResMed (NYSE:RMD) Sees Strong Trading Volume
marketbeat.com - April 17 at 4:53 PM
ResMed Unusual Options Activity For April 17ResMed Unusual Options Activity For April 17
benzinga.com - April 17 at 10:32 AM
Eli Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Test; ResMed DivesEli Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Test; ResMed Dives
investors.com - April 17 at 8:57 AM
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow downNeedham sees BSX, CNMD, RMD beating Street, despite medtech slow down
msn.com - April 14 at 6:59 PM
ResMed Inc. (NYSE:RMD) Shares Purchased by Mirae Asset Global Investments Co. Ltd.ResMed Inc. (NYSE:RMD) Shares Purchased by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - April 14 at 5:19 AM
Vaughan David Investments LLC IL Purchases New Holdings in ResMed Inc. (NYSE:RMD)Vaughan David Investments LLC IL Purchases New Holdings in ResMed Inc. (NYSE:RMD)
marketbeat.com - April 12 at 8:51 PM
Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in MarchShort interest in S&P 500 health stocks rises, Moderna among most shorted companies in March
msn.com - April 12 at 2:09 PM
ResMed Inc. Forecasted to Earn Q1 2025 Earnings of $1.94 Per Share (NYSE:RMD)ResMed Inc. Forecasted to Earn Q1 2025 Earnings of $1.94 Per Share (NYSE:RMD)
americanbankingnews.com - April 12 at 2:20 AM
ResMed Inc. Forecasted to Post Q1 2025 Earnings of $1.94 Per Share (NYSE:RMD)ResMed Inc. Forecasted to Post Q1 2025 Earnings of $1.94 Per Share (NYSE:RMD)
marketbeat.com - April 11 at 7:42 AM
Zacks Research Comments on ResMed Inc.s Q3 2024 Earnings (NYSE:RMD)Zacks Research Comments on ResMed Inc.'s Q3 2024 Earnings (NYSE:RMD)
americanbankingnews.com - April 11 at 1:36 AM
Hendershot Investments Inc. Acquires Shares of 44,068 ResMed Inc. (NYSE:RMD)Hendershot Investments Inc. Acquires Shares of 44,068 ResMed Inc. (NYSE:RMD)
marketbeat.com - April 10 at 7:55 PM
Q3 2024 EPS Estimates for ResMed Inc. Lifted by Analyst (NYSE:RMD)Q3 2024 EPS Estimates for ResMed Inc. Lifted by Analyst (NYSE:RMD)
marketbeat.com - April 10 at 8:28 AM
Nisa Investment Advisors LLC Has $11.50 Million Position in ResMed Inc. (NYSE:RMD)Nisa Investment Advisors LLC Has $11.50 Million Position in ResMed Inc. (NYSE:RMD)
marketbeat.com - April 9 at 6:38 AM
ResMed Inc. (NYSE:RMD) Given Average Recommendation of "Moderate Buy" by AnalystsResMed Inc. (NYSE:RMD) Given Average Recommendation of "Moderate Buy" by Analysts
americanbankingnews.com - April 9 at 2:32 AM
ResMed Inc. (NYSE:RMD) Receives Average Recommendation of "Moderate Buy" from AnalystsResMed Inc. (NYSE:RMD) Receives Average Recommendation of "Moderate Buy" from Analysts
marketbeat.com - April 9 at 2:30 AM
Financial Review: ResMed (NYSE:RMD) and Artivion (NYSE:AORT)Financial Review: ResMed (NYSE:RMD) and Artivion (NYSE:AORT)
americanbankingnews.com - April 9 at 1:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ANN logo

ANN

NYSE:ANN
ANN INC., through its wholly owned subsidiaries, is a specialty retailer of women's apparel, shoes and accessories sold primarily under the Ann Taylor and LOFT brands. The Company operates in four segments: Ann Taylor, LOFT, Ann Taylor Factory and LOFT Outlet. The Company operates approximately 1,030 retail stores in 47 states of the United States, the District of Columbia, Puerto Rico and Canada, comprising 245 Ann Taylor stores, 537 LOFT stores, 116 Ann Taylor Factory stores, 127 LOFT Outlet stores and five Lou & Grey stores. In addition, the Company's clients shop online in over 100 countries across the world at www.anntaylor.com and www.LOFT.com, and at three LOFT franchise locations in Mexico. The Company's wholly owned subsidiary, AnnTaylor Distribution Services, Inc., owns its 256,000 square foot distribution center located in Louisville, Kentucky. The distribution center is located on approximately 29 acres.
GuestLogix logo

GuestLogix

TSE:GXI
GuestLogix Inc. is a retailing and payment technology company. The Company offers a portfolio of hardware, software, content and professional services to travel operators across the world. The Company's segments include GuestLogix Onboard and OpenJaw. Its segments are engaged in providing merchandising, payment and business intelligence technology delivered to the passenger travel industry, both onboard and off-board. The Company focuses on providing retail technology that supports both the travel retail and ancillary revenue programs of the travel industry, such as the sale of onboard food and beverage, duty-free products, onboard entertainment (digital content), seat upgrades and ground ancillaries, such as hotels, car rentals and destination-content. It also serves clients using its retail systems to sell core product offerings, such as airline and rail tickets. Its network spans over 144 countries across the Americas, Europe, the Middle East and Africa (EMEA) and Asia Pacific.
ResMed logo

ResMed

NYSE:RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.